This curriculum vitae summarizes the educational background and professional experience of Prof. Sandeep Sidhu. He has an MBBS, MD, and DM in Gastroenterology, as well as fellowships in Interventional Endoscopy and Liver Transplantation. His research focuses on topics related to hepatology such as alcoholic hepatitis and hepatic encephalopathy. He has over 30 publications and has held appointments including Professor of Gastroenterology and Liver Transplantation. He maintains an active research program and sees patients at Dayanand Medical College & Hospital in Ludhiana.
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
All manuscripts are subject to rapid peer review. Those of high quality (not previously published and not under consideration for publication in another journal) will be published without delay
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease are strongly related, as 71% of patients with PSC have
ulcerative colitis (UC) and it seems that both diseases have shared genetic factors. IBD-PSC has different characteristics than IBD only. In patients with UC and PSC, the more common form of disease is pancolitis, and in Crohn’s disease patients with PSC is colitis. Also, IBD with concomitant PSC is less active and occurs at an earlier age. PSC is an additional risk factor for colorectal neoplasia in IBD patients and IBD increases the risk of developing gallbladder cancer and cholangiocarcinoma in PSC.
Background: The Oxford Classification of IgAN was developed in 2009. Subsequent validation studies found that M and E lesions were less predictive of ESRD. Varying reproducibility and lack of sufficient clinical relevance have since then resulted in several larger studies like the VALIGA study which addressed some of the shortcomings of the Oxford Classification. We had previously reported on a 30 year follow up study of 102 patients with IgA nephritis (IgAN) to validate the Oxford Classification and we showed that E and S lesions of the Oxford MEST were predictive of patients likely to develop renal failure during the initial 5 years of the disease whereas M and T scores were predictive of late renal failure as shown in our 30 years follow up of these patients. In this follow up study we explore how we could expand the relevant histological features of the MEST score as well as include some clinical indices to make the Oxford Classification more relevant clinically.
Study of Endothelial Dysfunction in Type 2 Diabetes Mellitusiosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
A study on the pharmacological management of mineral bone disease in chronick...PARUL UNIVERSITY
In patients with chronic kidney disease (CKD), along with progression of CKD,
abnormalities of mineral and bone metabolism develop, which result in altered serum levels of minerals
such as calcium and phosphorus, as well as abnormalities in parathyroid hormone (PTH) or vitamin D
metabolism. Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) is a serious burden because of
increased cardiovascular mortality thus making therapeutic improvements essential in CKD-MBD. The
present study was aimed at evaluation of pharmacological management of CKD-MBD.
Methods:A retrospective study including 180 patients divided into two groups of 90 each (diabetes
mellitus and non-Diabetes) was performed in the Department of Nephrology, SVIMS, Tirupati. Patients
who were on follow up for at least 3 years (2015-2017) were considered, serum parameters were measured at every six months with a total of 6 visits. First visit was taken as baseline and sixth visit as
conclusion.
Results:The disease incidence of CKD-MBD is more common in male patients i.e. 67.8%. Serum calcium
levels were significantly increased and eGFR was significantly decreased in all patients with CKD at
conclusion compared to baseline.Further, Serum calcium levels were significantly increased at conclusion
in CKD patients without DM and eGFR was significantly decreased at conclusion compared to baseline
in CKD patients with DM. The proportion of untreated patients is high for all the drugs except vitamin D
analogues in both subgroups of CKD patients.
Conclusion:Pharmacological intervention in CKD patients helps in the effective management of mineral
bone disease by maintaining serum calcium, phosphate and calcium phosphorous product status.
Dr. Prof. (Brig.) Atul Kumar Sood, VSM, Director & HOD - Best Gastroenterologist, Hepatologist & Stomach, Liver Specialist Doctor in Ghaziabad, Delhi NCR. He is recognized for his work in chronic liver disease, pancreatitis and IBD (Inflammatory Bowel Disease). Book appointment for Endoscopy , ERCP, EUS, colonoscopy, Liver Biopsy and Fibroscan. in Yashoda hospital Nehru Nagar Ghaziabad @ 9810922042.
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease are strongly related, as 71% of patients with PSC have
ulcerative colitis (UC) and it seems that both diseases have shared genetic factors. IBD-PSC has different characteristics than IBD only. In patients with UC and PSC, the more common form of disease is pancolitis, and in Crohn’s disease patients with PSC is colitis. Also, IBD with concomitant PSC is less active and occurs at an earlier age. PSC is an additional risk factor for colorectal neoplasia in IBD patients and IBD increases the risk of developing gallbladder cancer and cholangiocarcinoma in PSC.
Background: The Oxford Classification of IgAN was developed in 2009. Subsequent validation studies found that M and E lesions were less predictive of ESRD. Varying reproducibility and lack of sufficient clinical relevance have since then resulted in several larger studies like the VALIGA study which addressed some of the shortcomings of the Oxford Classification. We had previously reported on a 30 year follow up study of 102 patients with IgA nephritis (IgAN) to validate the Oxford Classification and we showed that E and S lesions of the Oxford MEST were predictive of patients likely to develop renal failure during the initial 5 years of the disease whereas M and T scores were predictive of late renal failure as shown in our 30 years follow up of these patients. In this follow up study we explore how we could expand the relevant histological features of the MEST score as well as include some clinical indices to make the Oxford Classification more relevant clinically.
Study of Endothelial Dysfunction in Type 2 Diabetes Mellitusiosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
A study on the pharmacological management of mineral bone disease in chronick...PARUL UNIVERSITY
In patients with chronic kidney disease (CKD), along with progression of CKD,
abnormalities of mineral and bone metabolism develop, which result in altered serum levels of minerals
such as calcium and phosphorus, as well as abnormalities in parathyroid hormone (PTH) or vitamin D
metabolism. Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) is a serious burden because of
increased cardiovascular mortality thus making therapeutic improvements essential in CKD-MBD. The
present study was aimed at evaluation of pharmacological management of CKD-MBD.
Methods:A retrospective study including 180 patients divided into two groups of 90 each (diabetes
mellitus and non-Diabetes) was performed in the Department of Nephrology, SVIMS, Tirupati. Patients
who were on follow up for at least 3 years (2015-2017) were considered, serum parameters were measured at every six months with a total of 6 visits. First visit was taken as baseline and sixth visit as
conclusion.
Results:The disease incidence of CKD-MBD is more common in male patients i.e. 67.8%. Serum calcium
levels were significantly increased and eGFR was significantly decreased in all patients with CKD at
conclusion compared to baseline.Further, Serum calcium levels were significantly increased at conclusion
in CKD patients without DM and eGFR was significantly decreased at conclusion compared to baseline
in CKD patients with DM. The proportion of untreated patients is high for all the drugs except vitamin D
analogues in both subgroups of CKD patients.
Conclusion:Pharmacological intervention in CKD patients helps in the effective management of mineral
bone disease by maintaining serum calcium, phosphate and calcium phosphorous product status.
Dr. Prof. (Brig.) Atul Kumar Sood, VSM, Director & HOD - Best Gastroenterologist, Hepatologist & Stomach, Liver Specialist Doctor in Ghaziabad, Delhi NCR. He is recognized for his work in chronic liver disease, pancreatitis and IBD (Inflammatory Bowel Disease). Book appointment for Endoscopy , ERCP, EUS, colonoscopy, Liver Biopsy and Fibroscan. in Yashoda hospital Nehru Nagar Ghaziabad @ 9810922042.
THERAPEUTIC EFFECT OF SOYA BEAN CHUNKS SUPPLEMENTION DURING HEMODIALYSISNeeleshkumar Maurya
The present study was conducted during the year 2016-17 on 30 ckd-5 patients on hemodialysis admitted in various medical wards of the MLB, Medical College, Jhansi (U.P.) India. The primary data were obtained from all CKD patients 30 days intervals and three times first time proper medication with hemodialysis therapy and second time same condition patients with additional dietary counseling. The data was collected in all the patients, thorough anthropometric measurement, dietary history and blood are collected for analysis of Hb, serum albumin, blood urea, cholesterol and cretonne. The Proper dietary counseling along with high biological protein (20 gm) given during hemodialysis superior the nutritional value of undernourished chronic kidney disease patient. About proper diet counseling of the patients showed significant statistical positive (<0.005) response in a various nutritional factor like BMI, MUAC, Serum Albumin, hemoglobin, total calorie intake while the only medication and dialysis therapy showed an undergoing undernourished in their nutritional value. The patients undergoing hemodialysis often develop protein-energy malnutrition which is related to mortality and morbidity rate increases. Special nutritional care is required for the dialysis patient to improve the net protein anabolism. The nutritional value of soya bean chunks in patients on HD requirements more attention providing one-to-one nutrition psychotherapy could be improvements in the patients. Key words : Dialysis, malnutrition, soybean chunks, high biological protein.
Pathophysiological mechanisms and consequences of gut edema (Annika Reintam W...WSACS
Gut edema in acute illness is not yet sufficiently studied and existing knowledge is largely based on experimental animal studies or small studies in healthy volunteers. However, increasing evidence confirms that gut edema impairs intestinal motility and healing of bowel anastomoses, being therefore an important contributor to outcome.
Current presentation focuses mainly on the role of fluids in development of intestinal edema.
Enhanced Recovery after Surgery its relevance - Evidence BasedDeep Goel
Enhanced recovery programs are evidence-based protocols designed to standardize medical care, improve outcomes, and lower health care costs. These protocols include evidence-based techniques to minimize surgical trauma and postoperative pain, reduce complications, improve outcomes, and decrease hospital length of stay, while expediting recovery following elective procedures.Protocols have been developed for colorectal surgery patients to reduce physiological stress and postoperative organ dysfunction through optimization of perioperative care and recovery
A Clinical Study to Evaluate the Efficacy of Yasthyadi Ksheera Basti in the M...ijtsrd
Background Hyperuricemia affects approximately 15.2 of men and 6.80 of women and around 11.1 of overall population. Vatarakta is correlated with Hyperuricemia is an acute chronic inflammatory condition of joint takes place predominantly where serum uric acid is raised beyond 6.8mg dl. It is estimated as much as 21 of the general population and 25 of hospitalized patients have asymptomatic hyperuricemia.Objectives 1. Conceptual study of Yashtyadi Ksheera Basti and Vatarakta.2. To clinically evaluate the efficacy of Yashtyadi Ksheera Basti in Vatarakta w.s.r. to Hyperuricemia. Methodology Study Design An observational clinical study with pre, mid and posttest design. Intervention 30 patients of Vatarakta hyperuricemia were randomly selected based on the signs and symptoms of Vatarakta hyperuricemia . Patients were assigned into a single group and subjected to Yashtyadi Ksheera Basti for 8days in Yogabasti pattern. Data was collected before intervention i.e. 0th day, after Basti Karma i.e. on 9th day and after Parihara Kala i.e. 16th day. Scoring was given to each of the symptoms using gradation index Dr. Siddharud S Byakod | Dr. Vijayakumar Tungal | Dr. Prashant Koppa "A Clinical Study to Evaluate the Efficacy of Yasthyadi Ksheera Basti in the Management of Vatarakta with Special Reference to Hyperuricemia" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-6 , October 2022, URL: https://www.ijtsrd.com/papers/ijtsrd52181.pdf Paper URL: https://www.ijtsrd.com/medicine/ayurvedic/52181/a-clinical-study-to-evaluate-the-efficacy-of-yasthyadi-ksheera-basti-in-the-management-of-vatarakta-with-special-reference-to-hyperuricemia/dr-siddharud-s-byakod
In this slide deck, I describe the up-to-date evidence on Low Carbs and heart health. The evidence is based mainly on two recent meta-analyses (Hession et al. & Kodama et al.) and prospective cohort studies. Limited evidence on renal aspects is also demonstrated.
Evaluation Of Aetiology Of Upper Gastro Intestinal Bleeding &Management In Th...iosrjce
Upper GI Bleeding is defined as Bleeding from GIT starting from oral cavity upto Ligamentum of
trietz .,it may be either a hematemesis, malena or both. Upper GI bleed is a quiet common problem seen in
day to day Gastroenterology OPD., & a detailed 5yrs study was made to assess the etiological factors for UGI
bleeding in the period from 2009-2014, in the department of Gastroenterology ,GGH/Guntur Medical college,
Guntur,AP.
1. Curriculum Vitae
Degrees & Fellowships
• MBBS, CMCH, Ldh 1984
• MD , CMCH. Ldh 1989
• DM, Gastroenterology [AIIMS, Delhi] 1992
• Fellowship, Interventional Endoscopy [ University of Hamburg, Germany],
1998
• Fellowship in Liver Transplantation [Cambridge, UK], 2011
Visiting Professor
Dept. of Hepatology & Liver Transplantation [Mayo Clinic], January 2016
Career Statement
Hepatology excites me. My current research focuses has been as follows
• Alcoholic Hepatitis
• Gabapentine in controlling alcohol abstinence
• Minimal Hepatic Encephalopathy
• Overt Hepatic Encephalopathy
2. • Hepato-Renal Syndrome Type I
Academic Awards and Distinctions
Post Doctorate of Medicine (DM ) in Gastroenterology
1. Invited Reviewer for New England of Medicine
The Massachusetts Medical Society, publisher of the New England Journal of
Medicine, certifies that
Prof. Sandeep Sidhu has participated in the manuscript review activity as part of
the NEJM Manuscript Review CME Program between July 1, 2014 and December
30, 2014 and is awarded 3 AMA PRA Category 1 Credit(s).™
2. Awarded the “Asia Pacific Young Investigator Award in Gastroenterology”
for the year 1996 at Yokohama, Japan , Sept 1996.
Current Appointment
Professor, in the Dept. of Gastroenterology and Liver Transplantation, Dayanand
Medical College & Hospital, Ludhiana
3. Publications
1. Sidhu SS, Goyal O, Parker R, Kishore H, Sood A. Rifaximin Versus
Lactulose in treatment of the Minimal hepatic encephalopathy in Patient
with Cirrhosis: A Prospective, Randomized, Active Comparator, Non-
Inferiority Trial. Liver Int. 2016 Mar;36(3):378-85.
2. Sidhu SS, Goyal O, Kashyap. Efficacy of Combination Therapy of
Glucocorticoids and Bovine Colostrum in Treatment of Severe Alcoholic
Hepatitis. (COBS).This study has been completed. (Submitted for
publication) ClinicalTrials.gov Identifier: NCT02265328
3. Sidhu SS, Parker R, Kishore, Sood A.Efficacy of intravenous ‘l-ornithine l
aspartate’ in reversal of overt acute hepatic encephalopathy in patients with
liver cirrhosis: a prospective, randomized, double-blind placebo controlled
trail” (Recruiting) ClinicalTrials.gov Identifier: NCT01722578.
4. Sidhu SS, Datta U, Sinha SK, Sharma BC, Shalimar K, Nijhawan K,
Narayana K, Kishore H. Comparison of Combination Therapy of
Corticosteroids and Bovine Colostrum Versus Corticosteroids and Placebo:
Randomized Double Blind Placebo Controlled Trial in Treatment of Severe
Alcoholic Hepatitis (COBRA) ClinicalTrials.gov Identifier: NCT02473341
5. Sidhu SS, Kishore H. Sorafenib induced Acute Overt Hepatic
Encephalopathy. Accepted in Acta Gastro-enterologica Belgica (Manuscript
number: Gastro-3908.R1) (In Press) 2015
4. 6. Sidhu SS. ALD Burden of Disease in India . Invited Review for ‘Journal of
Clinical and Experimental Hepatology (JCEH)', 2015
((http://www.jcehepatology.com/) Radha K DhimanMD (Editor-in-Chief)
7. Sidhu SS, Goyal O, Sood A. Noradrenaline is as effective as Terlipressin in
Hepatorenal Syndrome Type 1: a prospective, randomized trial (In Press:
Ann Hepatol) 2015
8. Sidhu SS, Gupta R, Sood A. Efficacy and safety of ribavirin in patients with
acute on chronic liver failure (ACLF) with hepatitis E virus infection as the
acute precipitating event (RACLF TRIAL: Ribavirin in Acute on Chronic
Liver Failure due to HEV). Hepatology Supplement Issue, Oct 2014,562 A.
9. E. Machytka , Z. Kowalczyk , F. Cappelletti , S. Walter , M. Ekstedt O.
Bednarska , S. Kechagias , E. Mathus-Vliegen , C. Lee , G. Farfan , H.
Munnings , R. Jirawan G. Marinos , V. Puig , P. Wolff , R. Kosai , A. Jasmi
J. Mason , V. Mehta , A. Sood , S. Sidhu , M. Chhabra , J. Brooks .
Implantation Of The Spatz 3 Adjustable Balloon System Without Guidewire
And Pusher.18th
World Congress of International Federation for the Surgery
of Obesity and Metabolic Disorders.August 2013, Istanbul , Turkey
(IFSO2013) A
10.Sidhu SS, Goyal O, Singla P, Gupta D, Sood A, Chhina RS, Soni RK.
Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone
for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial).Dig Dis
Sci. 2012 Jun;57(6):1664-71. Epub 2012 Mar 3.
5. 11.Sidhu SS, Goyal O, Singla M, Bhatia KL, Chhina RS, Sood A.
Pentoxifylline in Severe Alcoholic Hepatitis: A prospective randomized
trial. J Assoc Physicians India 2012;60:20-22.
12.Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin
improves Psychometric test performance and Health related quality of life in
patients with Minimal hepatic encephalopathy : a prospective randomized,
placebo controlled trial (RIME trial). Am J Gastroenterol 2011
Feb;106(2):307-16. Epub 2010 Dec 14.
13.Sidhu SS, Goyal O. Rifaximin in minimal hepatic encephalopathy: response
to Zullo et al. Am J Gastroenterol 2011;106(11):2041-2 (L)
14.Mohan B, Sidhu SS, Goyal O, Goyal P, Wander GS. Embolotherapy in
massive sphincterotomy bleed.J Assoc. Phys India 2010;58:44-45
15.Sidhu SS, Bery A, Puri H, Goyal O. Cholestatic hepatitis due to azathioprine
and tacrolimus in adult renal allograft recipient. Ind J Gastro 2008;27:249-
250
16.Sidhu SS. Space occupying lesions of the liver causing jaundice. In: Tandon
R and Acharya SK, eds. Clinical approach to jaundice 2005; 289-299
17.Sidhu SS. Nundy S, Tandon RK. The effect of the modified Puestow
procedure on diabetes in patients with tropical chronic pancreatitis – a
prospective study. Am J Gastroenterol. 2001 ; Jan 96(1); 107-11.
6. 18.Brand B, Kahl M, Sidhu S, Nam V C, Sriram PVJ, Jaeckle S, Thonke F,
Soehendra N. Prospective evaluation of morphology, function and quality
of life following ESWL and endoscopic therapy of chronic calcific
pancreatitis. Am J Gastroenterol 2000. Dec 95 (12); 3428-38.
19.Sood A, Midha V, Sekhon JS, Sidhu SS. Generalized cutaneous metastases
from carcinoma stomach. Am J Gastroenterol 1998. Sep 93 (9): 1601.
20.Sood A, Sidhu SS, Midha V, Jyoti D. High seroprevalence of Hepatitis C
virus and dual infection (Hepatitis B and C virus) in non alcoholic chronic
liver disease in North India. J Assoc Physicians India 1999. Feb : 47 (2):
205-8.
21.Sood A, Midha V, Sidhu SS. A case of enteric fever with unusual
manifestations. Trop Gastroenterol 1998: 19 (3):114
22.Garg PK, Sidhu SS, Bhargava DK. Role of omeperazole in prevention and
treatment of post endoscopic variceal sclerotherapy esophageal
complications: Double blind randomized study. Dig Dis Sci 1995; 40(7):
1569-74.
23.Sidhu SS, Bal CS, Karak PK, Garg PK, Bhargava DK. Effect of endoscopic
variceal sclerotherapy on esophageal motor functions and gastroesophageal
reflux. J Nuclear Med 1995; 36(8): 1363-1367.
24.Sidhu SS, Shah P, Prasanna BM, Srikanta SS, Tandon RK. Chronic calcific
panreatitis of the tropics : Spectrum and correlation of exocrine and
endocrine pancreatic dysfunction. Diabetes Research and Clin Pract 1995;
27:127-132.
7. 25.Sidhu SS , Shah P, Srikanta SS, Tandon RK. Ketosis resistant diabetes of the
young: A profile of the its exocrine and endocrine pancreatic dysfunction.
Indian J Physiol Pharmacol. 1995; 38(4):289-293.
26.Sidhu SS. Prognostic importance of small bowel gas in severe ulcerative
colitis. Tropical gastroenterol 1991; 12 (4):199-200.
27.Sidhu SS, Tandon RK. Chronic pancreatitis: Diagnosis and management.
Post Grad Med J 1996: 72(848):327-333.
28.Sidhu SS, Tandon RK. The pathogenesis of chronic pancreatitis. Post Grad
Med J 1995; 71 (832):67-70.
29. Sidhu, Sandeep; Goyal, Omesh; Mishra, Bholeshwar P.; Sood, Ajit; Chhina,
Rajoo S.; Soni, Ravinder K. Rifaximin improves Cognitive functions and
Health Related Quality of Life in patients with Minimal Hepatic
Encephalopathy: A prospective randomised double blind placebo controlled
trial (The RIME trial): Gastroenterology(S) May 2010 (A).
30.Sidhu SS, Goyal O, Singla P, Gupta D, Chhina RS, Sood A. A prospective
randomized trial to compare the efficacy of corticosteroids plus
pentoxifylline versus corticosteroids alone in the treatment of severe
alcoholic hepatitis. J Hepatol 2010 (A)
31.Goyal O, Goyal P, Singh J, Gupta S, Sidhu SS, Chhina RS, Sood A.
Clinico-etiological profile of hepatocellular carcinoma: a North Indian
prospective study. J Gastroenterol and Hepatol 2008; Sept ; 23(5): A67.
8. 32.Goyal O, Sehgal N, Puri S, Sidhu SS. Terlipressin versus noradrenaline in
hepatorenal syndrome : a prospective , randomized, unblinded study. J
Gastroenterol and Hepatol 2008; Sept: 23(5): A76.
33.Sidhu SS, Singla M, Bhatia KL. Pentoxifylline reduces disease severity and
prevents renal impairment in severe acute alcoholic hepatitis : A double
blind, placebo controlled trial. Hepatology 2006; Oct 44 (4):A373-374.
34.Brand B, Kahl M, Sidhu SS, Nam VC, Sriram PVJ, Jeckle S, Thonke F,
Soehendra N. Evaluation of morphology , function and quality of life
following ESWL and endoscopic therapy of chronic calcific pancreatitis . G
I Endosc 1999; 49:A648.
35.Sidhu SS, Satija VK, Manie AJ. Clinicopsychological profile of Irritable
Bowel Syndrome patients in North India. Digestion 1998; 59(3):A 693.
36.Sood A , Chhina RS, Sidhu SS, Midha V, Vij A. Azathioprine in steroid
dependent ulcerative colitis Digestion 1998; 59(3): A158.
37.Sidhu S, Nundy S, Tandon RK. Expanding indications of pancreatic
drainage surgery in chronic calcific pancreatitis in the tropics . 10th
Asia
Pacific Congress of Gastroenterology (Abstract Book), 1996, Yokohoma,
Japan.
38.Bal CS, Sidhu SS, Karak PK, Bhargava DK, Basu AK. The role of
eosophageal scintigraphy and barium studies in the management of
endoscopic variceal sclerotherapy: A prospective study J Nucl Med 1994;
34 (5): A168-169.
39.Sidhu SS, Tandon RK, Nundy S. Chronic calcific pancreatitis: A prospective
study of response to surgical treatment Indian J Gastoenterol 1994; 13(1):J2
9. 40.Bhargava DK, Sidhu SS, Bal CS, Karak PK. Esophageal luminal functions:
Effect of endoscopic variceal sclerotherapy . J Hepatol Gastroenterol 1992
A.
41.Sidhu SS, Bal CS, Bhargava DK. Esophageal sclerotherapy induced early
and late esophageal dysfunction and gatroesophageal reflux . Indian J
Gastroenterol 1992; 11(1):A6.
42.Sidhu SS, Shah P, Tandon RK. Insulin requiring diabetes of the young in
India : A profile of their exocrine and endocrine pancreatic dysfunction .
Indian J Gastroenterol 1992; 11(1):G8.
43.Bal CS, Sidhu SS, Karak PK, Bhargava DK, Basu AK. Esophageal
scintigraphy and gastroesophageal reflux studies during endoscopic
sclerotherapy : Serial evaluation in 14 patients Indian J Nucl Med 1992;
7(1) :A53
44.Sharma MP, Sidhu SS,. Chronic pancreatitis of the elderly . J Assoc Phys
India 1991; 39: A 893.
45.Sidhu SS, Shah P, Tandon RK. Does protein deficiency diabetes mellitus
exist? Diabetes Bulletin 1991; 11: A 28-29.
Chapter in Books
1.Sidhu S, Goyal O. Severe Alcoholic Hepatitis: Assessment of Severity and
Medical Management in 2014. In: Saraswat V, ed. Alcoholic Liver Disease
– A complete spectrum 2014; 74 – 94.
2. Sidhu SS, Sharma M. “Management of acute liver failure” In: Medicine
10. Update Book ; The 71st Annual conference of the Association of Physicians
of India: Hyderabad, 29th – 31st January 2016.